Found 41 matching trials
Immunomodulatory Effects of Silymarin in Patients With Beta-Thalassemia Major
PHASE1A wide spectrum of immune abnormalities has been described by numerous stud...
Location
Department of Immunology, School of Medicine, Shiraz University of Medical Sciences
Efficacy and Safety of Desferal Versus Osveral in Transfusional Iron Overload
NAThalassemic patients often suffer from iron overload due to frequent blood ...
Location
Hormozgan University of Medical Sciences (HUMS)
Desferal Administration to Improve the Impaired Reaction to Hypoxia in Diabetes
PHASE2The general aim of this study is to investigate the influence of systemic a...
Location
Karolinska University Hospital
Cardiac T2* in Beta-thalassemia Patients on Deferasirox Treatment
PHASE2The purpose of this trial is to evaluate changes in cardiac iron as measure...
Location
Childrens Hospital of Los Angeles
Compassionate Use of Deferiprone for Patients With Thalassemia and Iron-Induced Heart Disease
N/APatients who have iron overload due to chronic blood transfusions and have ...
Status
Approved For Marketing
Location
The Children's Hospital of Philadelphia
Intracerebral Hemorrhage Deferoxamine Trial - iDEF Ttrial
PHASE2The investigators hypothesize that treatment with the iron chelator, Defero...
Location
St. Joseph's Hospital / Barrow Neurological Institute
Study to Evaluate CD8 PET Imaging as a Marker of Immune Response to Stereotactic Body Radiation Therapy (ELIXR)
PHASE1"This phase I trial investigates the effect of radiation therapy on the imm...
Location
City of Hope Medical Center
The Fifth INTEnsive pReventing Secondary Injury in Acute Cerebral Haemorrhage Trial Within ACT-GLOBAL
PHASE3This is a domain within the ACT-GLOBAL platform trial to compare the effect...
Location
Royal Prince Alfred Hospital
Iron Balance Study of Deferasirox, Deferoxamine and the Combination of Both
PHASE1Subjects with thalassemia major require regular transfusion therapy to sust...
Location
Weill Cornell Medical Center
Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients With Resectable Brain Tumors
PHASE1This phase I trial studies how well zirconium (Zr)-89 crefmirlimab berdoxam...
Location
UCLA / Jonsson Comprehensive Cancer Center